With the expiration of neotame substance structure patent on August 7, 2015, Wuhan HuaSweet Co., Ltd prepared for FDA registration in accordance with the established development strategy. Under the leadership of the senior leaders of the company, employees worked together and successfully obtained the FDA registration certificate.
The successful registration of FDA marks the first step for HuaSweet to enter the European and American markets. Moreover, with its unique technology invention patent, HuaSweet is the only Neotame manufacturer in China to enter the European and American markets, becoming an industry model and contributing to the development of additives industries in China.